Dhiver C - Search Results

1

Toward chronic hepatitis C eradication in HIV-positive patients, including those cirrhotic and infected with genotype 3 viruses.

Menard A, Aherfi S, Mokhtari S, Dhiver C, Ravaux I, Tissot-Dupont H, Meddeb L, Brouqui P, Stein A, Colson P. Menard A, et al. Among authors: dhiver c. Gut. 2017 Oct;66(10):1868-1869. doi: 10.1136/gutjnl-2016-313431. Epub 2017 Jan 10. Gut. 2017. PMID: 28073889 No abstract available.

2

Absent inhibition of hepatitis B virus replication by azidothymidine in patients chronically coinfected by HIV-1 and HBV.

Gallian P, De Lamballerie X, Lehucher MP, Dhiver C, Ravaux I. Gallian P, et al. Among authors: dhiver c. New Microbiol. 1996 Apr;19(2):167-9. New Microbiol. 1996. PMID: 8722313

3

Multidrug resistance genotypes (insertions in the beta3-beta4 finger subdomain and MDR mutations) of HIV-1 reverse transcriptase from extensively treated patients: incidence and association with other resistance mutations.

Tamalet C, Yahi N, Tourrès C, Colson P, Quinson AM, Poizot-Martin I, Dhiver C, Fantini J. Tamalet C, et al. Among authors: dhiver c. Virology. 2000 May 10;270(2):310-6. doi: 10.1006/viro.2000.0261. Virology. 2000. PMID: 10792990 Free article.

4

Evolution of HIV-1 multidrug-resistant genotypes during combination therapy and after the cessation of antiretroviral drugs.

Yahi N, Tourrès C, Tivoli N, Colson P, Dhiver C, Quinson AM, Tamalet C. Yahi N, et al. Among authors: dhiver c. AIDS. 2000 Dec 22;14(18):2943-5. doi: 10.1097/00002030-200012220-00019. AIDS. 2000. PMID: 11153678 No abstract available.

5

Therapeutic drug monitoring of lopinavir/ritonavir given alone or with a non-nucleoside reverse transcriptase inhibitor.

Solas C, Poizot-Martin I, Drogoul MP, Ravaux I, Dhiver C, Lafeuillade A, Allegre T, Mokhtari M, Moreau J, Lepeu G, Petit N, Durand A, Lacarelle B. Solas C, et al. Among authors: dhiver c. Br J Clin Pharmacol. 2004 Apr;57(4):436-40. doi: 10.1046/j.1365-2125.2003.02020.x. Br J Clin Pharmacol. 2004. PMID: 15025741 Free PMC article.

6

Hepatitis E virus as a newly identified cause of acute viral hepatitis during human immunodeficiency virus infection.

Colson P, Dhiver C, Gérolami R. Colson P, et al. Among authors: dhiver c. Clin Microbiol Infect. 2008 Dec;14(12):1176-80. doi: 10.1111/j.1469-0691.2008.02102.x. Epub 2008 Nov 22. Clin Microbiol Infect. 2008. PMID: 19046170 Free article.

7

The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals.

HIV-CAUSAL Collaboration; Ray M, Logan R, Sterne JA, Hernández-Díaz S, Robins JM, Sabin C, Bansi L, van Sighem A, de Wolf F, Costagliola D, Lanoy E, Bucher HC, von Wyl V, Esteve A, Casbona J, del Amo J, Moreno S, Justice A, Goulet J, Lodi S, Phillips A, Seng R, Meyer L, Pérez-Hoyos S, García de Olalla P, Hernán MA. HIV-CAUSAL Collaboration, et al. AIDS. 2010 Jan 2;24(1):123-37. doi: 10.1097/QAD.0b013e3283324283. AIDS. 2010. PMID: 19770621 Free PMC article.

8

Acute and chronic hepatitis E in patients infected with human immunodeficiency virus.

Colson P, Dhiver C, Poizot-Martin I, Tamalet C, Gérolami R. Colson P, et al. Among authors: dhiver c. J Viral Hepat. 2011 Mar;18(3):227-8. doi: 10.1111/j.1365-2893.2010.01311.x. J Viral Hepat. 2011. PMID: 20384963 No abstract available.

9

Hepatitis E virus infection in patients infected with the human immunodeficiency virus.

Kaba M, Richet H, Ravaux I, Moreau J, Poizot-Martin I, Motte A, Nicolino-Brunet C, Dignat-George F, Ménard A, Dhiver C, Brouqui P, Colson P. Kaba M, et al. Among authors: dhiver c. J Med Virol. 2011 Oct;83(10):1704-16. doi: 10.1002/jmv.22177. J Med Virol. 2011. PMID: 21837786

10

Antiretroviral therapy does not block the secretion of the human immunodeficiency virus tat protein.

Mediouni S, Darque A, Baillat G, Ravaux I, Dhiver C, Tissot-Dupont H, Mokhtari M, Moreau H, Tamalet C, Brunet C, Paul P, Dignat-George F, Stein A, Brouqui P, Spector SA, Campbell GR, Loret EP. Mediouni S, et al. Among authors: dhiver c. Infect Disord Drug Targets. 2012 Feb;12(1):81-6. doi: 10.2174/187152612798994939. Infect Disord Drug Targets. 2012. PMID: 22280310

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

105 results

Search Page